相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The effect of adding exenatide to a thiazolidinedione in suboptimally controlled type 2 diabetes - A randomized trial
Bernard Zinman et al.
ANNALS OF INTERNAL MEDICINE (2007)
A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study
M. A. Nauck et al.
DIABETOLOGIA (2007)
Metabolic effects of two years of exenatide treatment on diabetes, obesity, and hepatic biomarkers in patients with type 2 diabetes: An interim analysis of data from the open-label, uncontrolled extension of three double-blind, placebo-controlled trials
John B. Buse et al.
CLINICAL THERAPEUTICS (2007)
Exenatide elicits sustained glycaemic control and progressive reduction of body weight in patients with type 2 diabetes inadequately controlled by sulphonylureas with or without metformin
Matthew C. Riddle et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2006)
Insulin treatment and the problem of weight gain in type 2 diabetes
Catherine Carver
DIABETES EDUCATOR (2006)
Interim analysis of the effects of exenatide treatment on A1C, weight and cardiovascular risk factors over 82 weeks in 314 overweight patients with type 2 diabetes
L. Blonde et al.
DIABETES OBESITY & METABOLISM (2006)
Understanding diabetes medications from the perspective of patients with type 2 diabetes - Prerequisite to medication concordance
Risa P. Hayes et al.
DIABETES EDUCATOR (2006)
The definition of weight maintenance
J Stevens et al.
INTERNATIONAL JOURNAL OF OBESITY (2006)
Addition of rapid-acting insulin to basal insulin therapy in type 2 diabetes: indications and modalities
L Monnier et al.
DIABETES & METABOLISM (2006)
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea
DM Kendall et al.
DIABETES CARE (2005)
Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes
RA DeFronzo et al.
DIABETES CARE (2005)
Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes
JB Buse et al.
DIABETES CARE (2004)
Synthetic exendin-4 (Exenatide) significantly reduces postprandial and fasting plasma glucose in subjects with type 2 diabetes
OG Kolterman et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Obesity and disease management: Effects of weight loss on comorbid conditions
JW Anderson et al.
OBESITY RESEARCH (2001)
Exendin-4 reduces fasting and postprandial glucose and decreases energy intake in healthy volunteers
CMB Edwards et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2001)
Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro
DG Parkes et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2001)
Combination therapies with insulin in type 2 diabetes
H Yki-Järvinen
DIABETES CARE (2001)
分享论文
